Related Experiment Videos
[Two new steroidal saponins from Allium macrostemon]
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 1, 1992
Summary
Two novel steroidal saponins, macrostemonoside A and D, were isolated from Allium macrostemon. Macrostemonoside A demonstrated significant inhibition of rabbit platelet aggregation, suggesting potential therapeutic applications for myocardial infarction.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Pharmacology
Context:
- Traditional Chinese Medicine (TCM) utilizes Allium macrostemon (Xie bai) for cardiovascular conditions.
- Myocardial infarction remains a leading cause of mortality worldwide.
- Understanding the active compounds in TCM is crucial for drug discovery.
Purpose:
- To isolate and characterize novel steroidal saponins from Allium macrostemon.
- To evaluate the pharmacological activity of the isolated compounds, specifically their effect on platelet aggregation.
Summary:
- Two new steroidal saponins, macrostemonoside A and D, were identified from Allium macrostemon bulbs.
- Their chemical structures were elucidated using spectral and chemical methods.
- Macrostemonoside A exhibited potent inhibition of adenosine diphosphate (ADP)-induced rabbit platelet aggregation in vitro, with an IC50 of 0.065 mmol.
Impact:
- This research identifies potential novel anti-platelet agents from a TCM source.
- Macrostemonoside A's activity suggests a possible mechanism for Allium macrostemon's use in treating myocardial infarction.
- Further investigation could lead to the development of new cardiovascular drugs.